Merck KGaA. (2/10/25). "Press Release: Merck Confirms Discussions with SpringWorks Therapeutics, Inc. on Potential Acquisition". Darmstadt.

	Organisation	Merck KGaA
	Group	Merck (DE) (Group)
	Organisation 2	SpringWorks Therapeutics Inc. (Nasdaq: SWTX)
	Product	pharmaceutical
	Product 2	investment banking
	Person	Schrimpf, Gangolf (Merck (DE) 201708)

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

Merck KGaA (“Merck”) reacts to press reports and confirms advanced discussions with SpringWorks Therapeutics, Inc.. Merck also confirms that no legally binding agreement has been entered into. There is no certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.

End of inside information

For more information, please contact Gangolf Schrimpf
+49 151 1454-9591
Email

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

Record changed: 2025-03-08